AzTrials
AzTrials

Surgical Site InfectionClean CareNCT04676841

Wound Contamination During Orthopaedic Surgery

An observational study of Surgical Site Infection and Hip Fractures, run by Vastra Gotaland Region at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the present study we will compare bacteriological findings and the incidence of SSI in relation to laminar airflow (LAF) ventilated ORs, conventional (also called displacement or mixed) ventilated ORs and conventional ventilated ORs with the addition of tables equipped with units providing a local LAF over the… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Conventional ventilation + instrumental tables with integrated laminar airflow, Conventional ventilation + standard instrumental tables and Laminar airflow ventilation + standard instrumental tables
Type of treatment
Medical device
How many people
100 participants
Where
1 siteSweden
Study dates
1 Sep 2019to Nov 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Hip fracture patients operated with hemiarthroplasty

Who may be able to join

  • Patients undergoing hip fracture surgery treated with hemiarthroplasty implant and that are subsequently cared for at participating ortho-geriatric unit

Who cannot join

  • Patients that will not give their informed consent.
  • Patient that, at the time of surgery, have an infection in any part of the body, hospital or community acquired.
  • Patients receiving fracture fixation with pins only

Trial locations and contacts

1 site in 1 country.

Sweden1 site, 1 recruiting
  • Department of Ortopedics, Sahlgrenska University Hospital

    Mölndal, 43180

    Annette Erichsen Andersson, +46 73 725 04 58

    Recruiting

Other trials in Sweden

About this study

Official title: Assessment of Relationships Between Airborne Microorganisms and Wound Contamination During Orthopaedic Surgery - a Trial Within the Clean Care Project

In the present study we will compare bacteriological findings and the incidence of SSI in relation to laminar airflow (LAF) ventilated ORs, conventional (also called displacement or mixed) ventilated ORs and conventional ventilated ORs with the addition of tables equipped with units providing a local LAF over the surgical instruments.

The hypothesis is that there exist a correlation between number and types of airborne bacteria and bacteria in the surgical wound and on surgical instruments at the time of wound closure.

Read the detailed description

The scientific literature on the relationship between airborne bacteria and wound contamination during different conditions is scares. A study from 1982 (Whyet et al.), demonstrated that the most important and consistent source of contamination of the wound during clean surgery (in this case hip implant surgery) was via air. The study concluded that approximately one third of bacteria in the wound were caused by direct air contamination whereas the remaining number of bacteria were transferred to the wound by indirect routes such as via contaminated instruments.

The present study includes patients undergoing hemiarthroplastic surgery due to hip fracture.

During the surgery active air sampling, for microbial analysis, will be done within 30 cm from the wound.

Passive sampling of instrument tables, to measure number of depositing bacteria on the surface during the procedure, will be performed by placing sterile filters on the table surfaces before initiating the surgical procedure and collecting them at the end.

Skin and wound sampling will be performed with sterile flocked nylon swabs. The method for skin and wound sampling was decided based on a literature review and discussions with the department of Clinical microbiology at Sahlgrenska University hospital. Both aerobe and anaerobe bacteria will be analyzed.

The wound will be measured and number of personnel, door openings and clothing, at each procedure will be recorded.

Patients included in the study will be interviewed after 6 weeks and 1 year, to evaluate incidence rate of SSI.

Being tested
Conventional ventilation + instrumental tables with integrated laminar airflow, Conventional ventilation + standard instrumental tables, Laminar airflow ventilation + standard instrumental tables
Keywords
LAF, UDF, SSI, Wound contamination, Infection control, Airborne contamination, Operating room
Medical subject headings
Surgical Wound Infection, Hip Fractures, Musculoskeletal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional ventilation + instrumental tables with integrated laminar airflowDevice

    Surgical instruments protected from contamination by local laminar airflow

  • Conventional ventilation + standard instrumental tablesDevice

    Control

  • Laminar airflow ventilation + standard instrumental tablesDevice

    Control

Study groups in NCT04676841
Study groupRoleWhat they receive
HemiarthroplastyHip fracture patients operated with hemiarthroplasty
Receives: Device: Conventional ventilation + instrumental tables with integrated laminar airflow; Device: Conventional ventilation + standard instrumental tables; Device: Laminar airflow ventilation + standard instrumental tables

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Live bacterial Count (colony forming units, CFU) per meter3 air during surgery; in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    Active airsampling within 30cm from the surgical wound will be performed during surgery and number of collected aerobe and anaerobe bacteria analyzed.

    Measured: 2019-2021

  2. Number of CFU in the surgical wound before closure; after surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    The entire wound is swabed before closure, aerobe and anaerobe bacteria analyzed.

    Measured: 2019-2021

Secondary outcomes (5)
  1. CFU/dm2 on the patients skin Before directly prior to incission, before surgery in surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    Swab sample is taken of the skin directly prior to incission, aerobe and anaerobe bacteria analyzed.

    Measured: 2019-2022

  2. CFU/dm2 on the instrument tables during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    Passive sampling of bacteria falling down on the instrument tables during the duration of each surgical procedure will be analyzed. Aerobe and anaerobe bacteria analyzed.

    Measured: 2019-2022

  3. Bacterial species in air collected during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    The bacterial species in collected samples are identified with MALDI-TOF

    Measured: 2019-2022

  4. Bacterial species in wound samples collected during surgery in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    The bacterial species in collected samples are identified with MALDI-TOF

    Measured: 2019-2022

  5. Number and sort of SSI in patients operated in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables

    Patients are contacted 6 weeks and 1 year after surgery and incidense and severrensess of infection recorded

    Measured: 2019-2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2020
  2. Study start1 Sep 2019
  3. Primary completionNov 2021 (estimated)
  4. Study completionNov 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04676841
Sponsor's protocol ID
2019-02180
Other IDs
2019
Acronym
Clean Care
Status last verified
Nov 2020
First submitted
17 Nov 2020
Last updated
21 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Surgical Site Infection and Hip Fractures, run by Vastra Gotaland Region at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Annette Erichsen Andersson (+46 73 725 04 58, annette.erichsen.andersson@gu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Live bacterial Count (colony forming units, CFU) per meter3 air during surgery; in ORs with LAF ventilation, Conventional ventilation or Conventional ventilation + local LAF above instrument tables (time frame: 2019-2021). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in